phrykt

Resmed (RMD) revenue: $5.7B

Resmed reported $5.7B of revenue for the year ended Jun 30, 2026, up 9.9% from $5.1B a year earlier.

From Resmed's filings with the SEC · Read the filing · RMD stock page

Resmed revenue by year

$3.2B2021$3.6B2022$4.2B2023$4.7B2024$5.1B2025$5.7B2026

#643 of 3,622 US companies by revenue · See the full ranking

Year endedRevenueChange
Jun 30, 2026$5.7B+10%
Jun 30, 2025$5.1B+10%
Jun 30, 2024$4.7B+11%
Jun 30, 2023$4.2B+18%
Jun 30, 2022$3.6B+12%
Jun 30, 2021$3.2B–

Revenue of similar companies

Companies in the same industry as Resmed, by SEC industry code, with the closest revenue. Each name opens the same page for that company.

CompanyRevenue, latest yearYear ended
Baxter International$11.2BDec 31, 2025
Solventum$8.3BDec 31, 2025
Resmed$5.7BJun 30, 2026
Dexcom$4.7BDec 31, 2025
MiniMed Group$3.1BApr 24, 2026
West Pharmaceutical Services$3.1BDec 31, 2025
Globus Medical$2.9BDec 31, 2025

Questions and answers

What is Resmed's revenue?

Resmed reported $5.7B of revenue for the year ended Jun 30, 2026, up 9.9% from $5.1B a year earlier.

Numbers as reported in Resmed's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology